Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
暂无分享,去创建一个
T. Funahashi | I. Shimomura | S. Fukuda | H. Nishizawa | N. Maeda | Hirotaka Sawano | Tomoaki Natsukawa | Y. Hayashi | Y. Fujishima | Tatsuro Kai | Masaya Yamaoka | H. Nagao | F. Sato
[1] N. Ouchi. Adipocytokines in Cardiovascular and Metabolic Diseases. , 2016, Journal of atherosclerosis and thrombosis.
[2] T. Kitamoto,et al. CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass. , 2016, Journal of atherosclerosis and thrombosis.
[3] H. Selker,et al. Serum adiponectin levels in patients with acute coronary syndromes: Serial changes and relation to infarct size , 2015, Diabetes & vascular disease research.
[4] L. Hsu,et al. Association of CDH13 Genotypes/Haplotypes with Circulating Adiponectin Levels, Metabolic Syndrome, and Related Metabolic Phenotypes: The Role of the Suppression Effect , 2015, PloS one.
[5] J. Marinković,et al. Time-dependent changes of plasma adiponectin concentration in relation to coronary microcirculatory function in patients with acute myocardial infarction treated by primary percutaneous coronary intervention. , 2015, Journal of cardiology.
[6] T. Funahashi,et al. Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice. , 2015, Endocrinology.
[7] M. Kals,et al. CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs , 2014, Human Genetics.
[8] P. Armstrong,et al. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. , 2014, American heart journal.
[9] T. Funahashi,et al. A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J study , 2014, Cardiovascular Diabetology.
[10] A. Baumbach,et al. Infarct size reduction in acute myocardial infarction , 2014, Heart.
[11] Yukiko Nakamura,et al. Ultrastructural Localization of Adiponectin protein in Vasculature of Normal and Atherosclerotic mice , 2014, Scientific Reports.
[12] Y. Teo,et al. Genetic Variation in CDH13 Is Associated With Lower Plasma Adiponectin Levels but Greater Adiponectin Sensitivity in East Asian Populations , 2013, Diabetes.
[13] S. Kihara,et al. Adiponectin Protein Exists in Aortic Endothelial Cells , 2013, PloS one.
[14] Ryosuke Kikuchi,et al. T-cadherin Is Essential for Adiponectin-mediated Revascularization* , 2013, The Journal of Biological Chemistry.
[15] T. Funahashi,et al. Cardiovascular-metabolic impact of adiponectin and aquaporin. , 2013, Endocrine journal.
[16] J. Jordan,et al. Atrial Natriuretic Peptide and Adiponectin Interactions in Man , 2012, PloS one.
[17] Y. Kokubo,et al. CDH13 gene coding t‐cadherin influences variations in plasma adiponectin levels in the Japanese population , 2012, Human mutation.
[18] I. Shimomura,et al. Induced Adipocyte Cell-Sheet Ameliorates Cardiac Dysfunction in a Mouse Myocardial Infarction Model: A Novel Drug Delivery System for Heart Failure , 2011, Circulation.
[19] Wen-Harn Pan,et al. A Genome-Wide Association Study Reveals a Quantitative Trait Locus of Adiponectin on CDH13 That Predicts Cardiometabolic Outcomes , 2011, Diabetes.
[20] W. Koch,et al. Downregulation of adiponectin induced by tumor necrosis factor &agr; is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury* , 2011, Critical care medicine.
[21] P. Buszman,et al. Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model. , 2011, International journal of molecular medicine.
[22] P. Ruiz-Lozano,et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.
[23] M. Matsuzaki,et al. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. , 2010, Atherosclerosis.
[24] T. Murohara,et al. Impact of a Single Intracoronary Administration of Adiponectin on Myocardial Ischemia/Reperfusion Injury in a Pig Model , 2010, Circulation. Cardiovascular interventions.
[25] T. Funahashi,et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.
[26] Jonathan C. Cohen,et al. Genome‐wide Linkage and Association Analyses to Identify Genes Influencing Adiponectin Levels: The GEMS Stud , 2009, Obesity.
[27] S. Kihara,et al. Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction. , 2008, The American journal of cardiology.
[28] S. Kihara,et al. Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-&agr; , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[29] J. Ottervanger,et al. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. , 2008, American heart journal.
[30] A. Hirayama,et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials , 2007, The Lancet.
[31] S. Kihara,et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. , 2007, Cardiovascular research.
[32] Walter Koch,et al. Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress , 2007, Circulation.
[33] S. Kihara,et al. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. , 2006, Kidney international.
[34] Kazuo Kimura,et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. , 2006, Journal of the American College of Cardiology.
[35] G. Stone,et al. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. , 2006, Journal of the American College of Cardiology.
[36] S. Kihara,et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.
[37] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[38] 熊田 全裕. Association of hypoadiponectinemia with coronary artery disease in men , 2004 .
[39] S. Kihara,et al. Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[40] S. Kihara,et al. Erratum , 2003, Heart.
[41] S. Kihara,et al. Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[42] M. Matsuda,et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.
[43] S. Kihara,et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.
[44] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[45] S. Kihara,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.
[46] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[47] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[48] M. Cohen,et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. , 1985, Journal of the American College of Cardiology.
[49] C. W. Small,et al. Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. , 1975, Circulation.
[50] T. Funahashi,et al. Adiponectin and the cardiometabolic syndrome: an epidemiological perspective. , 2014, Best practice & research. Clinical endocrinology & metabolism.
[51] T. Funahashi,et al. Cardiovascular-metabolic impact of adiponectin and aquaporin [Review] , 2013 .
[52] M. Matsuda,et al. Effect of pravastatin on the development of diabetes and adiponectin production. , 2008, Atherosclerosis.
[53] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.